Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-ca13-14-01803/USCOURTS-ca13-14-01803-0/pdf.json

Parties Involved:
Camber Pharmaceuticals Inc.
Appellee
Invagen Pharmaceuticals Inc.
Appellee
Roxane Laboratories, Inc.
Appellant

Document Text:

NOTE: This disposition is nonprecedential.

United States Court of Appeals 

for the Federal Circuit ______________________ 

ROXANE LABORATORIES, INC.,

Plaintiff-Appellant

v.

CAMBER PHARMACEUTICALS INC., INVAGEN 

PHARMACEUTICALS INC.,

Defendants-Appellees

______________________ 

2014-1803

______________________ 

Appeal from the United States District Court for the 

District of New Jersey in No. 2:14-cv-04042-SRC-CLW, 

Judge Stanley R. Chesler.

______________________ 

JUDGMENT

______________________ 

KENNETH G. SCHULER, Latham & Watkins LLP, Chicago, IL, argued for plaintiff-appellant. Also represented 

by MARC NATHAN ZUBICK; ALEXANDER ENRICO LONG, San 

Diego, CA; GREGORY SOBOLSKI, San Francisco, CA; 

ROBERT J. GAJARSA, Washington, DC.

ROBERT S. SILVER, Caesar, Rivise, Bernstein, Cohen & 

Pokotilow, Ltd., Philadelphia, PA, argued for defendantsCase: 14-1803 Document: 52-2 Page: 1 Filed: 03/12/2015
 

appellees. Also represented by JAMES J. KOZUCH,

SALVATORE GUERRIERO, PEI-RU WEY. 

______________________ 

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED: 

 PER CURIAM (LOURIE, REYNA, and CHEN, Circuit 

Judges).

AFFIRMED. See Fed. Cir. R. 36.

 ENTERED BY ORDER OF THE COURT

March 12, 2015 /s/ Daniel E. O’Toole

Date Daniel E. O’Toole 

 Clerk of Court 

Case: 14-1803 Document: 52-2 Page: 2 Filed: 03/12/2015